@article{Liaki2025,
  author = {Liaki, V. and Barrambana, S. and Kostopoulou, M. and Lechuga, C. G. and others},
  title = {A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {51},
  pages = {e2412835122},
  doi = {10.1073/pnas.2412835122},
  note = {Published December 2025}
}

@misc{DepMap,
  author = {{Cancer Dependency Map Consortium}},
  title = {DepMap: Cancer Dependency Map},
  howpublished = {\url{https://depmap.org}},
  year = {2024}
}

@article{OmniPath,
  author = {Turei, D. and Korcsm{\'a}ros, T. and Saez-Rodriguez, J.},
  title = {OmniPath: guidelines and gateway for literature-curated signaling pathway resources},
  journal = {Nature Methods},
  volume = {13},
  pages = {966--967},
  year = {2016}
}

@article{Corsello2020,
  author = {Corsello, S. M. and Nagari, R. T. and Spangler, R. D. and Rossen, J. and Kocak, M. and Bryan, J. G. and others},
  title = {Discovering the anticancer potential of non-oncology drugs by systematic viability profiling},
  journal = {Nature Cancer},
  volume = {1},
  pages = {235--248},
  year = {2020},
  doi = {10.1038/s43018-019-0018-6}
}

@article{Bergholz2021,
  author = {Bergholz, J. S. and Zhao, J. J.},
  title = {How compensatory mechanisms and adaptive rewiring have shaped our understanding of therapeutic resistance in cancer},
  journal = {Cancer Research},
  volume = {81},
  number = {24},
  pages = {6074--6077},
  year = {2021},
  doi = {10.1158/0008-5472.CAN-21-3605}
}

@article{Xin2024,
  author = {Xin, Y. and Zhang, H. and Li, Y. and others},
  title = {Drug resistance mechanisms in cancers: Execution of pro-survival strategies},
  journal = {Acta Pharmaceutica Sinica B},
  volume = {14},
  number = {7},
  pages = {2943--2960},
  year = {2024},
  doi = {10.1016/j.apsb.2024.02.027}
}

@article{Chougule2016,
  author = {Chougule, R. A. and Kazi, J. U. and R{\"o}nnstrand, L.},
  title = {{FYN} expression potentiates {FLT3-ITD} induced {STAT5} signaling in acute myeloid leukemia},
  journal = {Oncotarget},
  volume = {7},
  number = {9},
  pages = {9964--9974},
  year = {2016},
  doi = {10.18632/oncotarget.7128}
}

@article{Zhang2020FYN,
  author = {Zhang, Y. and Wang, Y. and Zhang, B. and Li, P. and Zhao, J.},
  title = {{FYN} promotes gastric cancer metastasis by activating {STAT3} and predicts poor prognosis in patients},
  journal = {Journal of Cancer},
  year = {2020},
  volume = {11},
  number = {17},
  pages = {5072--5083},
  doi = {10.7150/jca.45236},
  note = {PMC7408597}
}

@article{Ma2025,
  author = {Ma, Z. and Peng, Y. and Gong, Y. and others},
  title = {Highlight on a Phase {III} Clinical Candidate Daraxonrasib ({RMC-6236}): Discovery, Optimization, and Biological Evaluation},
  journal = {Journal of Medicinal Chemistry},
  volume = {68},
  number = {12},
  pages = {10167--10183},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c01441}
}

@article{Ioannou2011,
  author = {Ioannou, N. and Dalgleish, A. G. and Seddon, A. M. and others},
  title = {Anti-tumour activity of afatinib, an irreversible {ErbB} family blocker, in human pancreatic tumour cells},
  journal = {British Journal of Cancer},
  volume = {105},
  number = {10},
  pages = {1554--1562},
  year = {2011},
  doi = {10.1038/bjc.2011.396}
}

@article{Huguet2016,
  author = {Huguet, F. and Fernet, M. and Giocanti, N. and Favaudon, V. and Larsen, A. K.},
  title = {Afatinib, an Irreversible {EGFR} Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of {KRAS} Status},
  journal = {Targeted Oncology},
  volume = {11},
  number = {3},
  pages = {371--381},
  year = {2016},
  doi = {10.1007/s11523-015-0403-8}
}

@article{Bai2019,
  author = {Bai, L. and Zhou, H. and Xu, R. and others},
  title = {Structure-Based Discovery of {SD-36} as a Potent, Selective, and Efficacious {PROTAC} Degrader of {STAT3} Protein},
  journal = {Journal of Medicinal Chemistry},
  volume = {62},
  number = {15},
  pages = {6774--6789},
  year = {2019},
  doi = {10.1021/acs.jmedchem.9b01530}
}

@article{VeraLicona2013,
  author = {Vera-Licona, P. and Bonnet, E. and Barillot, E. and Zinovyev, A.},
  title = {{OCSANA}: optimal combinations of interventions from network analysis},
  journal = {Bioinformatics},
  volume = {29},
  number = {12},
  pages = {1571--1573},
  year = {2013},
  doi = {10.1093/bioinformatics/btt195}
}

@article{Murakami2017,
  author = {Murakami, Y. and Tripathi, L. P. and Prathipati, P. and Mizuguchi, K.},
  title = {Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery},
  journal = {Current Opinion in Structural Biology},
  volume = {44},
  pages = {134--142},
  year = {2017},
  doi = {10.1016/j.sbi.2017.02.005}
}

@article{Dempster2021,
  author = {Dempster, J. M. and Boyle, I. and Vazquez, F. and others},
  title = {Chronos: a cell population dynamics model of {CRISPR} experiments that improves inference of gene fitness effects},
  journal = {Genome Biology},
  volume = {22},
  pages = {343},
  year = {2021},
  doi = {10.1186/s13059-021-02540-7}
}

@article{Tsherniak2017,
  author = {Tsherniak, A. and Vazquez, F. and Montgomery, P. G. and others},
  title = {Defining a Cancer Dependency Map},
  journal = {Cell},
  volume = {170},
  number = {3},
  pages = {564--576},
  year = {2017},
  doi = {10.1016/j.cell.2017.06.010}
}

@article{Turei2026,
  author = {T{\"u}rei, D. and Valdeolivas, A. and Gul, L. and others},
  title = {{OmniPath}: integrated knowledgebase for multi-omics analysis},
  journal = {Nucleic Acids Research},
  volume = {54},
  number = {D1},
  pages = {D652--D662},
  year = {2026},
  doi = {10.1093/nar/gkae1022}
}

@article{Yang2013,
  author = {Yang, W. and Soares, J. and Greninger, P. and others},
  title = {Genomics of Drug Sensitivity in Cancer ({GDSC}): a resource for therapeutic biomarker discovery in cancer cells},
  journal = {Nucleic Acids Research},
  volume = {41},
  number = {D1},
  pages = {D955--D961},
  year = {2013},
  doi = {10.1093/nar/gks1111}
}

@article{Iorio2016,
  author = {Iorio, F. and Knijnenburg, T. A. and Vis, D. J. and others},
  title = {A Landscape of Pharmacogenomic Interactions in Cancer},
  journal = {Cell},
  volume = {166},
  number = {3},
  pages = {740--754},
  year = {2016},
  doi = {10.1016/j.cell.2016.06.017}
}

@article{Behan2019,
  author = {Behan, F. M. and Iorio, F. and Picco, G. and others},
  title = {Prioritization of cancer therapeutic targets using {CRISPR-Cas9} screens},
  journal = {Nature},
  volume = {568},
  number = {7753},
  pages = {511--516},
  year = {2019},
  doi = {10.1038/s41586-019-1103-9}
}

@article{Shimada2021,
  author = {Shimada, K. and Bachman, J. A. and Muhlich, J. L. and others},
  title = {shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data},
  journal = {eLife},
  volume = {10},
  pages = {e57116},
  year = {2021},
  doi = {10.7554/eLife.57116}
}

@article{Eisenberg2013,
  author = {Eisenberg, E. and Levanon, E. Y.},
  title = {Human housekeeping genes, revisited},
  journal = {Trends in Genetics},
  volume = {29},
  number = {10},
  pages = {569--574},
  year = {2013},
  doi = {10.1016/j.tig.2013.05.010}
}

@article{Hounkpe2021,
  author = {Hounkpe, B. W. and Chenou, F. and de Lima, F. and De Paula, E. V.},
  title = {{HRT Atlas v1.0} database: redefining human and mouse housekeeping genes and candidate reference transcripts by mining massive {RNA-seq} datasets},
  journal = {Nucleic Acids Research},
  volume = {49},
  number = {D1},
  pages = {D947--D955},
  year = {2021},
  doi = {10.1093/nar/gkaa609}
}

@article{Pan2018,
  author = {Pan, J. and Meyers, R. M. and Michel, B. C. and others},
  title = {Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens},
  journal = {Cell Systems},
  volume = {6},
  number = {5},
  pages = {555--568},
  year = {2018},
  doi = {10.1016/j.cels.2018.04.011}
}

@book{Cohen1988,
  author = {Cohen, J.},
  title = {Statistical Power Analysis for the Behavioral Sciences},
  edition = {2nd},
  publisher = {Lawrence Erlbaum Associates},
  year = {1988}
}

@article{Elahi2018,
  author = {Elahi, F. E. and Hasan, A.},
  title = {A method for estimating Hill function-based dynamic models of gene regulatory networks},
  journal = {Royal Society Open Science},
  volume = {5},
  number = {2},
  pages = {171226},
  year = {2018},
  doi = {10.1098/rsos.171226}
}

@article{Long2014,
  author = {Long, G. V. and Stroyakovskiy, D. and Gogas, H. and others},
  title = {Combined {BRAF} and {MEK} inhibition versus {BRAF} inhibition alone in melanoma},
  journal = {New England Journal of Medicine},
  volume = {371},
  number = {20},
  pages = {1877--1888},
  year = {2014},
  doi = {10.1056/NEJMoa1406037}
}

@article{Robert2015,
  author = {Robert, C. and Karaszewska, B. and Schachter, J. and others},
  title = {Improved overall survival in melanoma with combined dabrafenib and trametinib},
  journal = {New England Journal of Medicine},
  volume = {372},
  number = {1},
  pages = {30--39},
  year = {2015},
  doi = {10.1056/NEJMoa1412690}
}

@article{Finn2015,
  author = {Finn, R. S. and Crown, J. P. and Lang, I. and others},
  title = {The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, {HER2}-negative, advanced breast cancer ({PALOMA-1/TRIO-18}): a randomised phase 2 study},
  journal = {The Lancet Oncology},
  volume = {16},
  number = {1},
  pages = {25--35},
  year = {2015},
  doi = {10.1016/S1470-2045(14)71159-3}
}

@article{Cristofanilli2016,
  author = {Cristofanilli, M. and Turner, N. C. and Bondarenko, I. and others},
  title = {Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, {HER2}-negative metastatic breast cancer that progressed on previous endocrine therapy ({PALOMA-3}): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial},
  journal = {The Lancet Oncology},
  volume = {17},
  number = {4},
  pages = {425--439},
  year = {2016},
  doi = {10.1016/S1470-2045(15)00613-0}
}

@article{Yu2004,
  author = {Yu, H. and Jove, R.},
  title = {The {STATs} of cancer---new molecular targets come of age},
  journal = {Nature Reviews Cancer},
  volume = {4},
  number = {2},
  pages = {97--105},
  year = {2004},
  doi = {10.1038/nrc1275},
  note = {PMID:14964307}
}

@article{Johnson2018,
  author = {Johnson, D. E. and O'Keefe, R. A. and Grandis, J. R.},
  title = {Targeting the {IL-6/JAK/STAT3} signalling axis in cancer},
  journal = {Nature Reviews Clinical Oncology},
  volume = {15},
  pages = {234--248},
  year = {2018},
  doi = {10.1038/nrclinonc.2018.8},
  note = {PMID:29405201}
}

@article{Frank2007,
  author = {Frank, D. A.},
  title = {{STAT3} as a central mediator of neoplastic cellular transformation},
  journal = {Cancer Letters},
  volume = {251},
  number = {2},
  pages = {199--210},
  year = {2007},
  doi = {10.1016/j.canlet.2006.10.017},
  note = {PMID:17129668}
}

@article{Jonker2018,
  author = {Jonker, D. J. and Nott, L. and Yoshino, T. and others},
  title = {Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial},
  journal = {The Lancet Gastroenterology \& Hepatology},
  volume = {3},
  number = {4},
  pages = {263--270},
  year = {2018},
  doi = {10.1016/S2468-1253(18)30009-8}
}

@article{Li2015,
  author = {Li, Y. and Rogoff, H. A. and Keates, S. and others},
  title = {Suppression of cancer relapse and metastasis by inhibiting cancer stemness},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {112},
  number = {6},
  pages = {1839--1844},
  year = {2015},
  doi = {10.1073/pnas.1424171112}
}

@article{Spring2020,
  author = {Spring, L. M. and Wander, S. A. and Andre, F. and Moy, B. and Turner, N. C. and Bardia, A.},
  title = {Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future},
  journal = {The Lancet},
  volume = {395},
  number = {10226},
  pages = {817--827},
  year = {2020},
  doi = {10.1016/S0140-6736(20)30165-3}
}

@article{Roberts2012,
  author = {Roberts, P. J. and Bisi, J. E. and Strum, J. C. and others},
  title = {Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy},
  journal = {Journal of the National Cancer Institute},
  volume = {104},
  number = {6},
  pages = {476--487},
  year = {2012},
  doi = {10.1093/jnci/djs002}
}

@article{Szklarczyk2025,
  author = {Szklarczyk, D. and Kirsch, R. and Koutrouli, M. and others},
  title = {STRING database in 2025: protein networks with directionality, expanded organism coverage, and new evidence channels},
  journal = {Nucleic Acids Research},
  volume = {53},
  number = {D1},
  pages = {D730--D738},
  year = {2025},
  doi = {10.1093/nar/gkae1123}
}

% ============================
% Gold-standard clinical trial citations
% ============================

@article{Planchard2016,
  author = {Planchard, D. and Besse, B. and Groen, H. J. and others},
  title = {Dabrafenib plus trametinib in patients with previously treated {BRAF V600E}-mutant metastatic non-small cell lung cancer},
  journal = {The Lancet Oncology},
  volume = {17},
  number = {7},
  pages = {984--993},
  year = {2016},
  doi = {10.1016/S1470-2045(16)30146-2},
  note = {PMID:27283860}
}

@article{Kopetz2019,
  author = {Kopetz, S. and Grothey, A. and Yaeger, R. and others},
  title = {Encorafenib, binimetinib, and cetuximab in {BRAF V600E}-mutated colorectal cancer},
  journal = {New England Journal of Medicine},
  volume = {381},
  number = {17},
  pages = {1632--1643},
  year = {2019},
  doi = {10.1056/NEJMoa1908075},
  note = {PMID:31566309}
}

@article{Larkin2014,
  author = {Larkin, J. and Ascierto, P. A. and Dr{\'e}no, B. and others},
  title = {Combined vemurafenib and cobimetinib in {BRAF}-mutated melanoma},
  journal = {New England Journal of Medicine},
  volume = {371},
  number = {20},
  pages = {1867--1876},
  year = {2014},
  doi = {10.1056/NEJMoa1408868},
  note = {PMID:25105994}
}

@article{Park2021,
  author = {Park, K. and Haura, E. B. and Leighl, N. B. and others},
  title = {Amivantamab in {EGFR} exon 20 insertion-mutated non-small-cell lung cancer},
  journal = {Journal of Clinical Oncology},
  volume = {39},
  number = {30},
  pages = {3391--3402},
  year = {2021},
  doi = {10.1200/JCO.21.00662},
  note = {PMID:34043995}
}

@article{Sequist2020,
  author = {Sequist, L. V. and Han, J. Y. and Ahn, M. J. and others},
  title = {Osimertinib plus savolitinib in patients with {EGFR} mutation-positive, {MET}-amplified, non-small-cell lung cancer after progression on {EGFR} tyrosine kinase inhibitors},
  journal = {The Lancet Oncology},
  volume = {21},
  number = {3},
  pages = {373--386},
  year = {2020},
  doi = {10.1016/S1470-2045(19)30785-5},
  note = {PMID:32234522}
}

@article{Baselga2012,
  author = {Baselga, J. and Bradbury, I. and Eidtmann, H. and others},
  title = {Lapatinib with trastuzumab for {HER2}-positive early breast cancer ({NeoALTTO})},
  journal = {The Lancet},
  volume = {379},
  number = {9816},
  pages = {633--640},
  year = {2012},
  doi = {10.1016/S0140-6736(11)61847-3},
  note = {PMID:22153890}
}

@article{Turner2015,
  author = {Turner, N. C. and Ro, J. and Andr{\'e}, F. and others},
  title = {Palbociclib in hormone-receptor-positive advanced breast cancer},
  journal = {New England Journal of Medicine},
  volume = {373},
  number = {3},
  pages = {209--219},
  year = {2015},
  doi = {10.1056/NEJMoa1505270},
  note = {PMID:26394241}
}

@article{Motzer2015,
  author = {Motzer, R. J. and Hutson, T. E. and Glen, H. and others},
  title = {Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma},
  journal = {The Lancet Oncology},
  volume = {16},
  number = {15},
  pages = {1473--1482},
  year = {2015},
  doi = {10.1016/S1470-2045(15)00290-9},
  note = {PMID:26116099}
}

@article{Daver2022,
  author = {Daver, N. and Perl, A. E. and Maly, J. and others},
  title = {Venetoclax plus gilteritinib for {FLT3}-mutated relapsed/refractory acute myeloid leukemia},
  journal = {Journal of Clinical Oncology},
  volume = {40},
  number = {35},
  pages = {4048--4059},
  year = {2022},
  doi = {10.1200/JCO.22.00602},
  note = {PMID:35443125}
}

@article{Ciruelos2024,
  author = {Ciruelos, E. and Villagrasa, P. and Pascual, T. and others},
  title = {Palbociclib and trastuzumab in {HER2}-positive advanced breast cancer: results from the phase {III} {PATINA} trial},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/JCO.22.02520},
  note = {PMID:36631847}
}

@article{Bhardwaj2019,
  author = {Bhardwaj, V. and Zhan, Y. and Cortez, M. A. and others},
  title = {{MET} inhibitor ficlatuzumab combined with cetuximab in head and neck squamous cell carcinoma},
  journal = {Cancer Letters},
  year = {2019},
  doi = {10.1016/j.canlet.2020.05.010},
  note = {PMID:32416071}
}

% ============================
% Benchmarking methodology citations
% ============================

@article{Julkunen2023,
  author = {Julkunen, H. and Cichonska, A. and Srivastava, M. and Alemany, S. and Kaski, S. and Rousu, J.},
  title = {Modeling drug combination effects via latent tensor reconstruction},
  journal = {Bioinformatics},
  volume = {39},
  number = {Supplement\_1},
  pages = {i43--i51},
  year = {2023},
  doi = {10.1093/bioinformatics/btad237},
  note = {PMC:10022091}
}

@article{Azadifar2024,
  author = {Azadifar, S. and Ahmadi, M. and Wren, J. D.},
  title = {Graph-based approaches for drug combination prediction: recent advances, challenges, and perspectives},
  journal = {Briefings in Bioinformatics},
  volume = {25},
  number = {3},
  year = {2024},
  doi = {10.1093/bib/bbae172}
}

@article{Menden2019,
  author = {Menden, M. P. and Wang, D. and Mason, M. J. and others},
  title = {Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen},
  journal = {Nature Communications},
  volume = {10},
  pages = {2674},
  year = {2019},
  doi = {10.1038/s41467-019-09799-2},
  note = {DREAM Challenge. PMID:31380352}
}

@article{Holbeck2017,
  author = {Holbeck, S. L. and Camalier, R. and Crowell, J. A. and others},
  title = {The {National Cancer Institute ALMANAC}: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity},
  journal = {Cancer Research},
  volume = {77},
  number = {13},
  pages = {3564--3576},
  year = {2017},
  doi = {10.1158/0008-5472.CAN-17-0489},
  note = {PMID:28446463}
}

@article{Benjamini1995,
  author = {Benjamini, Yoav and Hochberg, Yosef},
  title = {Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing},
  journal = {Journal of the Royal Statistical Society: Series B (Methodological)},
  volume = {57},
  number = {1},
  pages = {289--300},
  year = {1995},
  doi = {10.1111/j.2517-6161.1995.tb02031.x}
}

@article{Meyers2017,
  author = {Meyers, Robin M. and Bryan, Jordan G. and McFarland, James M. and Weir, Barbara A. and Sizemore, Ann E. and Xu, Han and Dharia, Neekesh V. and Montgomery, Philip G. and Cowley, Glenn S. and Pantel, Sasha and others},
  title = {Computational correction of copy number effect improves specificity of {CRISPR-Cas9} essentiality screens in cancer cells},
  journal = {Nature Genetics},
  volume = {49},
  number = {12},
  pages = {1779--1784},
  year = {2017},
  doi = {10.1038/ng.3984},
  note = {PMID:29083409}
}

@article{Preuer2018,
  author = {Preuer, Kristina and Lewis, Richard P. I. and Hochreiter, Sepp and Bender, Andreas and Bulusu, Krishna C. and Klambauer, G{\"u}nter},
  title = {{DeepSynergy}: predicting anti-cancer drug synergy with deep learning},
  journal = {Bioinformatics},
  volume = {34},
  number = {9},
  pages = {1538--1546},
  year = {2018},
  doi = {10.1093/bioinformatics/btx806},
  note = {PMID:29253077}
}

@article{Jaaks2022,
  author = {Jaaks, Patricia and Coker, Elizabeth A. and Vis, Daniel J. and Edwards, Olivia and Carpenter, Emily F. and Leto, Simonetta M. and Dwane, Lisa and Sasber, Rizwan and Golber, Mark and Lamba, Samixa and others},
  title = {Effective drug combinations in breast, colon and pancreatic cancer cells},
  journal = {Nature},
  volume = {603},
  number = {7903},
  pages = {166--173},
  year = {2022},
  doi = {10.1038/s41586-022-04437-6},
  note = {PMID:35197630}
}

@article{Pacini2021,
  author = {Pacini, Clare and Dempster, Joshua M. and Boyle, Isabella and Gon\c{c}alves, Emanuel and Najgebauer, Hanna and Karakoc, Emre and van der Meer, Dennis and Barthorpe, Andrew and Lightfoot, Howard and Jaaks, Patricia and others},
  title = {Integrated cross-study datasets of genetic dependencies in cancer},
  journal = {Nature Communications},
  volume = {12},
  pages = {1661},
  year = {2021},
  doi = {10.1038/s41467-021-21898-7},
  note = {PMID:33712601}
}

@article{Li2024bbae172,
  author = {Li, Yinghong and Yang, Yinqi and Tong, Zhuohao and Wang, Yu and Mi, Qin and Bai, Mingze and Liang, Guizhao and Li, Bo and Shu, Kunxian},
  title = {A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods},
  journal = {Briefings in Bioinformatics},
  volume = {25},
  number = {3},
  pages = {bbae172},
  year = {2024},
  doi = {10.1093/bib/bbae172}
}

@article{Subramanian2017,
  author = {Subramanian, Aravind and Narayan, Rajiv and Corsello, Steven M. and Peck, David D. and Natoli, Ted E. and Lu, Xiaodong and Gould, Joshua and Davis, John F. and Tubelli, Andrew A. and Asiedu, Jacob K. and Lahr, David L. and Hirschman, Jodi E. and Liu, Zihan and Donahue, Melanie and Julian, Bina and Khan, Musrat and Wadden, David and Smith, Ian C. and Lam, Daniel and Liberzon, Arthur and Tong, Courtney and Moore, Marielle and Hilber, Stephanie and Chetah, Mismisut and Gates, Elizabeth A. and Korber, Courtney and Shih, Justin and Harding, Sara E. and Vrcic, Maria and Golub, Todd R.},
  title = {A Next Generation Connectivity Map: {L1000} Platform and the First 1,000,000 Profiles},
  journal = {Cell},
  volume = {171},
  number = {6},
  pages = {1437--1452.e17},
  year = {2017},
  doi = {10.1016/j.cell.2017.10.049},
  note = {PMID:29195078}
}

@article{Lamb2006,
  author = {Lamb, Justin and Crawford, Emily D. and Peck, David and Modell, Joshua W. and Blat, Irene C. and Wrobel, Matthew J. and Lerner, Jim and Brunet, Jean-Philippe and Subramanian, Aravind and Ross, Kenneth N. and Reich, Michael and Hieronymus, Haley and Wei, Guo and Armstrong, Scott A. and Haggarty, Stephen J. and Clemons, Paul A. and Wei, Ru and Carr, Steven A. and Lander, Eric S. and Golub, Todd R.},
  title = {The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease},
  journal = {Science},
  volume = {313},
  number = {5795},
  pages = {1929--1935},
  year = {2006},
  doi = {10.1126/science.1132939},
  note = {PMID:17008526}
}

@article{Lin2017,
  author = {Lin, Ann and Giuliano, Christopher J. and Palladino, Annabelle and John, Kristen M. and Abramowicz, Christine and Yuan, Monet Lou and Sausville, Edward L. and Lukow, Devon A. and Liu, Luwei and Chait, Alexander R. and Galluzzo, Zachary C. and Tucker, Craig and Bhatt, Vishal and Hu, Jessie and Sheltzer, Jason M.},
  title = {{CRISPR/Cas9} mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials},
  journal = {eLife},
  volume = {6},
  pages = {e24179},
  year = {2017},
  doi = {10.7554/eLife.24179}
}

@article{Goncalves2020,
  author = {Gon{\c{c}}alves, Emanuel and Segura-Cabrera, Aldo and Pacini, Clare and Picco, Gabriele and Behan, Fiona M. and Jaaks, Patricia and Coker, Elizabeth A. and van der Meer, Donny and Barthorpe, Andrew and Lightfoot, Howard and Mironenko, Tatiana and Beck, Alexandra and Richardson, Laura and Yang, Wanjuan and Garnari, Frank B. and Iorio, Francesco and Garnett, Mathew J.},
  title = {Drug mechanism-of-action discovery through the integration of pharmacological and {CRISPR} screens},
  journal = {Molecular Systems Biology},
  volume = {16},
  number = {7},
  pages = {e9405},
  year = {2020},
  doi = {10.15252/msb.20199405}
}

@article{BenDavid2018,
  author = {Ben-David, Uri and Siranosian, Benjamin and Ha, Gavin and Tang, Helen and Oren, Yaara and Hinohara, Kunihiko and Strathdee, Craig A. and Dempster, Joshua and Lyber, Natasha J. and Burns, Robert and Nag, Anwesha and Kugener, Guillaume and Cimini, Beth and Tsvetkov, Peter and Maruvka, Yosef E. and Meyerson, Matthew and Golub, Todd R. and Beroukhim, Rameen and Piccioni, Federica and Root, David E. and Hahn, William C. and Tsherniak, Aviad and Vazquez, Francisca},
  title = {Genetic and transcriptional evolution alters cancer cell line drug response},
  journal = {Nature},
  volume = {560},
  number = {7718},
  pages = {325--330},
  year = {2018},
  doi = {10.1038/s41586-018-0409-3}
}

@article{Norman2019,
  author = {Norman, Thomas M. and Horlbeck, Max A. and Replogle, Joseph M. and Ge, Alex Y. and Xu, Albert and Jost, Marco and Gilbert, Luke A. and Weissman, Jonathan S.},
  title = {Exploring genetic interaction manifolds constructed from rich single-cell phenotypes},
  journal = {Science},
  volume = {365},
  number = {6455},
  pages = {786--793},
  year = {2019},
  doi = {10.1126/science.aax4438}
}

@article{Shen2017combCRISPR,
  author = {Shen, John Paul and Zhao, Dongxin and Sasik, Roman and Luebeck, Jens and Birmingham, Amanda and Bojorquez-Gomez, Ana and Licon, Kevin and Kleber, Kathleen and Downum, Daniel S. and Tate, Thomas and Chan, Allen N. and Perber, Brenton R. and Gross, Andrew and Ideker, Trey},
  title = {Combinatorial {CRISPR}-{Cas9} screens for de novo mapping of genetic interactions},
  journal = {Nature Methods},
  volume = {14},
  number = {6},
  pages = {573--576},
  year = {2017},
  doi = {10.1038/nmeth.4225}
}

@article{Yu2009STAT3immunity,
  author = {Yu, Hua and Pardoll, Drew and Jove, Richard},
  title = {{STATs} in cancer inflammation and immunity: a leading role for {STAT3}},
  journal = {Nature Reviews Cancer},
  volume = {9},
  number = {11},
  pages = {798--809},
  year = {2009},
  doi = {10.1038/nrc2734}
}

@article{Kortylewski2005,
  author = {Kortylewski, Marcin and Kujawski, Maciej and Wang, Tianhong and Wei, Sailan and Zhang, Sheng and Pilon-Thomas, Shari and Niu, Guilian and Kay, Hua and Mul{\'e}, James and Kerr, William G. and Jove, Richard and Pardoll, Drew and Yu, Hua},
  title = {Inhibiting {Stat3} signaling in the hematopoietic system elicits multicomponent antitumor immunity},
  journal = {Nature Medicine},
  volume = {11},
  number = {12},
  pages = {1314--1321},
  year = {2005},
  doi = {10.1038/nm1325}
}

@article{Vinh2010,
  author = {Vinh, Nguyen Xuan and Epps, Julien and Bailey, James},
  title = {Information Theoretic Measures for Clusterings Comparison: Variants, Properties, Normalization and Correction for Chance},
  journal = {Journal of Machine Learning Research},
  volume = {11},
  pages = {2837--2854},
  year = {2010}
}
